TOP1_MOUSE
ID TOP1_MOUSE Reviewed; 767 AA.
AC Q04750; A2A4B7;
DT 01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT 24-JUL-2007, sequence version 2.
DT 03-AUG-2022, entry version 180.
DE RecName: Full=DNA topoisomerase 1;
DE EC=5.6.2.1 {ECO:0000255|PROSITE-ProRule:PRU10130};
DE AltName: Full=DNA topoisomerase I;
GN Name=Top1; Synonyms=Top-1;
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Mus; Mus.
OX NCBI_TaxID=10090;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX PubMed=8096488; DOI=10.1016/0378-1119(93)90331-v;
RA Koiwai O., Yasui Y., Sakai Y., Watanabe T., Ishii K., Yanagihara S.,
RA Andoh T.;
RT "Cloning of the mouse cDNA encoding DNA topoisomerase I and chromosomal
RT location of the gene.";
RL Gene 125:211-216(1993).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA].
RA Hui C.-F., Lo C.K., Hwang J.;
RT "Cloning and characterization of mouse topoisomerase I cDNA.";
RL Submitted (JUL-1993) to the EMBL/GenBank/DDBJ databases.
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=C57BL/6J;
RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA Eichler E.E., Ponting C.P.;
RT "Lineage-specific biology revealed by a finished genome assembly of the
RT mouse.";
RL PLoS Biol. 7:E1000112-E1000112(2009).
RN [4]
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Spleen;
RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL Cell 143:1174-1189(2010).
RN [5]
RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-174, AND IDENTIFICATION BY MASS
RP SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Embryonic fibroblast;
RX PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT pathways.";
RL Mol. Cell 50:919-930(2013).
CC -!- FUNCTION: Releases the supercoiling and torsional tension of DNA
CC introduced during the DNA replication and transcription by transiently
CC cleaving and rejoining one strand of the DNA duplex. Introduces a
CC single-strand break via transesterification at a target site in duplex
CC DNA. The scissile phosphodiester is attacked by the catalytic tyrosine
CC of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-
CC enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free
CC DNA strand then rotates around the intact phosphodiester bond on the
CC opposing strand, thus removing DNA supercoils. Finally, in the
CC religation step, the DNA 5'-OH attacks the covalent intermediate to
CC expel the active-site tyrosine and restore the DNA phosphodiester
CC backbone. Regulates the alternative splicing of tissue factor (F3) pre-
CC mRNA in endothelial cells. Involved in the circadian transcription of
CC the core circadian clock component ARNTL/BMAL1 by altering the
CC chromatin structure around the ROR response elements (ROREs) on the
CC ARNTL/BMAL1 promoter. {ECO:0000250|UniProtKB:P11387}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP-independent breakage of single-stranded DNA, followed by
CC passage and rejoining.; EC=5.6.2.1; Evidence={ECO:0000255|PROSITE-
CC ProRule:PRU10130};
CC -!- SUBUNIT: Monomer (By similarity). Interacts with ERCC6 (By similarity).
CC {ECO:0000250|UniProtKB:P11387}.
CC -!- SUBCELLULAR LOCATION: Nucleus, nucleolus
CC {ECO:0000250|UniProtKB:P11387}. Nucleus, nucleoplasm
CC {ECO:0000250|UniProtKB:P11387}. Note=Diffuse nuclear localization with
CC some enrichment in nucleoli. On CPT treatment, cleared from nucleoli
CC into nucleoplasm. Sumoylated forms found in both nucleoplasm and
CC nucleoli. {ECO:0000250|UniProtKB:P11387}.
CC -!- PTM: Sumoylated. Lys-119 is the main site of sumoylation. Sumoylation
CC plays a role in partitioning TOP1 between nucleoli and nucleoplasm.
CC Levels are dramatically increased on camptothecin (CPT) treatment.
CC {ECO:0000250|UniProtKB:P11387}.
CC -!- PTM: Phosphorylation at Ser-508 by CK2 increases binding to supercoiled
CC DNA and sensitivity to camptothecin. {ECO:0000250|UniProtKB:P11387}.
CC -!- MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both
CC negative and positive supercoils, whereas prokaryotic enzymes relax
CC only negative supercoils.
CC -!- SIMILARITY: Belongs to the type IB topoisomerase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; D10061; BAA00950.1; -; mRNA.
DR EMBL; L20632; AAA40466.1; -; mRNA.
DR EMBL; AL590414; CAM20297.1; -; Genomic_DNA.
DR EMBL; AL591673; CAM20297.1; JOINED; Genomic_DNA.
DR EMBL; AL591673; CAM25349.1; -; Genomic_DNA.
DR EMBL; AL590414; CAM25349.1; JOINED; Genomic_DNA.
DR CCDS; CCDS16995.1; -.
DR PIR; JU0144; JU0144.
DR RefSeq; NP_033434.2; NM_009408.2.
DR AlphaFoldDB; Q04750; -.
DR SMR; Q04750; -.
DR BioGRID; 204275; 45.
DR CORUM; Q04750; -.
DR IntAct; Q04750; 10.
DR MINT; Q04750; -.
DR STRING; 10090.ENSMUSP00000105094; -.
DR BindingDB; Q04750; -.
DR ChEMBL; CHEMBL2814; -.
DR DrugCentral; Q04750; -.
DR iPTMnet; Q04750; -.
DR PhosphoSitePlus; Q04750; -.
DR SwissPalm; Q04750; -.
DR EPD; Q04750; -.
DR jPOST; Q04750; -.
DR MaxQB; Q04750; -.
DR PaxDb; Q04750; -.
DR PeptideAtlas; Q04750; -.
DR PRIDE; Q04750; -.
DR ProteomicsDB; 259154; -.
DR Antibodypedia; 3962; 453 antibodies from 42 providers.
DR DNASU; 21969; -.
DR Ensembl; ENSMUST00000109468; ENSMUSP00000105094; ENSMUSG00000070544.
DR GeneID; 21969; -.
DR KEGG; mmu:21969; -.
DR UCSC; uc008nqy.1; mouse.
DR CTD; 7150; -.
DR MGI; MGI:98788; Top1.
DR VEuPathDB; HostDB:ENSMUSG00000070544; -.
DR eggNOG; KOG0981; Eukaryota.
DR GeneTree; ENSGT00940000155006; -.
DR HOGENOM; CLU_009193_0_1_1; -.
DR InParanoid; Q04750; -.
DR OMA; GLRYQKW; -.
DR OrthoDB; 303947at2759; -.
DR PhylomeDB; Q04750; -.
DR TreeFam; TF105281; -.
DR BRENDA; 5.6.2.1; 3474.
DR Reactome; R-MMU-4615885; SUMOylation of DNA replication proteins.
DR BioGRID-ORCS; 21969; 22 hits in 73 CRISPR screens.
DR ChiTaRS; Top1; mouse.
DR PRO; PR:Q04750; -.
DR Proteomes; UP000000589; Chromosome 2.
DR RNAct; Q04750; protein.
DR Bgee; ENSMUSG00000070544; Expressed in ileal epithelium and 258 other tissues.
DR Genevisible; Q04750; MM.
DR GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR GO; GO:0001651; C:dense fibrillar component; ISO:MGI.
DR GO; GO:0001650; C:fibrillar center; ISO:MGI.
DR GO; GO:0001673; C:male germ cell nucleus; IDA:MGI.
DR GO; GO:0000228; C:nuclear chromosome; ISO:MGI.
DR GO; GO:0005730; C:nucleolus; ISO:MGI.
DR GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR GO; GO:0005634; C:nucleus; IDA:MGI.
DR GO; GO:0000932; C:P-body; ISO:MGI.
DR GO; GO:0043204; C:perikaryon; IDA:MGI.
DR GO; GO:0032993; C:protein-DNA complex; ISO:MGI.
DR GO; GO:0005524; F:ATP binding; ISO:MGI.
DR GO; GO:0003682; F:chromatin binding; ISO:MGI.
DR GO; GO:0031490; F:chromatin DNA binding; ISO:MGI.
DR GO; GO:0003677; F:DNA binding; ISO:MGI.
DR GO; GO:0003917; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; IDA:MGI.
DR GO; GO:0003690; F:double-stranded DNA binding; ISO:MGI.
DR GO; GO:0019904; F:protein domain specific binding; ISO:MGI.
DR GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:MGI.
DR GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR GO; GO:0003697; F:single-stranded DNA binding; ISO:MGI.
DR GO; GO:0097100; F:supercoiled DNA binding; ISO:MGI.
DR GO; GO:0006338; P:chromatin remodeling; ISS:UniProtKB.
DR GO; GO:0007059; P:chromosome segregation; IBA:GO_Central.
DR GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR GO; GO:0006260; P:DNA replication; IMP:MGI.
DR GO; GO:0006265; P:DNA topological change; IDA:MGI.
DR GO; GO:0040016; P:embryonic cleavage; IMP:MGI.
DR GO; GO:0018105; P:peptidyl-serine phosphorylation; ISO:MGI.
DR GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl.
DR GO; GO:0009303; P:rRNA transcription; ISO:MGI.
DR CDD; cd00659; Topo_IB_C; 1.
DR Gene3D; 1.10.10.41; -; 1.
DR Gene3D; 1.10.132.10; -; 1.
DR Gene3D; 2.170.11.10; -; 1.
DR Gene3D; 3.90.15.10; -; 1.
DR InterPro; IPR011010; DNA_brk_join_enz.
DR InterPro; IPR013034; DNA_topo_DNA_db_N_dom1.
DR InterPro; IPR013030; DNA_topo_DNA_db_N_dom2.
DR InterPro; IPR001631; TopoI.
DR InterPro; IPR018521; TopoI_AS.
DR InterPro; IPR025834; TopoI_C_dom.
DR InterPro; IPR014711; TopoI_cat_a-hlx-sub_euk.
DR InterPro; IPR014727; TopoI_cat_a/b-sub_euk.
DR InterPro; IPR013500; TopoI_cat_euk.
DR InterPro; IPR008336; TopoI_DNA-bd_euk.
DR InterPro; IPR036202; TopoI_DNA-bd_euk_N_sf.
DR InterPro; IPR013499; TopoI_euk.
DR Pfam; PF14370; Topo_C_assoc; 1.
DR Pfam; PF01028; Topoisom_I; 1.
DR Pfam; PF02919; Topoisom_I_N; 1.
DR PRINTS; PR00416; EUTPISMRASEI.
DR SMART; SM00435; TOPEUc; 1.
DR SUPFAM; SSF56349; SSF56349; 1.
DR SUPFAM; SSF56741; SSF56741; 1.
DR PROSITE; PS00176; TOPOISOMERASE_I_EUK; 1.
PE 1: Evidence at protein level;
KW Acetylation; Biological rhythms; Direct protein sequencing; DNA-binding;
KW Isomerase; Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW Topoisomerase; Ubl conjugation.
FT INIT_MET 1
FT /note="Removed"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CHAIN 2..767
FT /note="DNA topoisomerase 1"
FT /id="PRO_0000145202"
FT REGION 1..201
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 427..428
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT REGION 490..495
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT REGION 587..589
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT COMPBIAS 1..26
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 36..201
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 725
FT /note="O-(3'-phospho-DNA)-tyrosine intermediate"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10130"
FT SITE 318
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT SITE 366
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT SITE 414
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT SITE 445
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT SITE 503
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT SITE 534
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT SITE 576
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT SITE 634
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT SITE 652
FT /note="Interaction with DNA"
FT /evidence="ECO:0000250"
FT MOD_RES 2
FT /note="N-acetylserine"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT MOD_RES 2
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT MOD_RES 10
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT MOD_RES 59
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT MOD_RES 114
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT MOD_RES 174
FT /note="N6-acetyllysine; alternate"
FT /evidence="ECO:0007744|PubMed:23806337"
FT MOD_RES 282
FT /note="N6-acetyllysine"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT MOD_RES 508
FT /note="Phosphoserine; by CK2"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 103
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 105
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO); alternate"
FT /evidence="ECO:0000305"
FT CROSSLNK 105
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2); alternate"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 119
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO); alternate"
FT /evidence="ECO:0000250"
FT CROSSLNK 119
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO1); alternate"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 119
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2); alternate"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 136
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 150
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 155
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO); alternate"
FT /evidence="ECO:0000305"
FT CROSSLNK 155
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2); alternate"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 160
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 166
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 174
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2); alternate"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 206
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 338
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 551
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 644
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 702
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CROSSLNK 714
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:P11387"
FT CONFLICT 91
FT /note="R -> P (in Ref. 2; AAA40466)"
FT /evidence="ECO:0000305"
FT CONFLICT 121
FT /note="E -> D (in Ref. 1; BAA00950)"
FT /evidence="ECO:0000305"
FT CONFLICT 129
FT /note="A -> V (in Ref. 2; AAA40466)"
FT /evidence="ECO:0000305"
FT CONFLICT 161
FT /note="Missing (in Ref. 2; AAA40466)"
FT /evidence="ECO:0000305"
FT CONFLICT 167
FT /note="S -> L (in Ref. 2; AAA40466)"
FT /evidence="ECO:0000305"
FT CONFLICT 277
FT /note="R -> W (in Ref. 2; AAA40466)"
FT /evidence="ECO:0000305"
FT CONFLICT 292
FT /note="E -> G (in Ref. 1; BAA00950)"
FT /evidence="ECO:0000305"
FT CONFLICT 522
FT /note="G -> V (in Ref. 2; AAA40466)"
FT /evidence="ECO:0000305"
FT CONFLICT 533
FT /note="G -> W (in Ref. 2; AAA40466)"
FT /evidence="ECO:0000305"
FT CONFLICT 762
FT /note="D -> Y (in Ref. 2; AAA40466)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 767 AA; 90876 MW; 4EA654244F07D5C1 CRC64;
MSGDHLHNDS QIEADFRLND SHKHKDKHKD REHRHKEHKK DKDKDREKSK HSNSEHKDSE
KKHKEKEKTK HKDGSSEKHK DKHKDRDKER RKEEKIRAAG DAKIKKEKEN GFSSPPRIKD
EPEDDGYFAP PKEDIKPLKR LRDEDDADYK PKKIKTEDIK KEKKRKSEEE EDGKLKKPKN
KDKDKKVAEP DNKKKKPKKE EEQKWKWWEE ERYPEGIKWK FLEHKGPVFA PPYEPLPESV
KFYYDGKVMK LSPKAEEVAT FFAKMLDHEY TTKEIFRKNF FKDWRKEMTN DEKNTITNLS
KCDFTQMSQY FKAQSEARKQ MSKEEKLKIK EENEKLLKEY GFCVMDNHRE RIANFKIEPP
GLFRGRGNHP KMGMLKRRIM PEDIIINCSK DAKVPSPPPG HKWKEVRHDN KVTWLVSWTE
NIQGSIKYIM LNPSSRIKGE KDWQKYETAR RLKKCVDKIR NQYREDWKSK EMKVRQRAVA
LYFIDKLALR AGNEKEEGET ADTVGCCSLR VEHINLHPEL DGQEYVVEFD FPGKDSIRYY
NKVPVEKRVF KNLQLFMENK QPEDDLFDRL NTGILNKHLQ DLMEGLTAKV FRTYNASITL
QQQLKELTAP DENVPAKILS YNRANRAVAI LCNHQRAPPK TFEKSMMNLQ SKIDAKKDQL
ADARRDLKSA KADAKVMKDA KTKKVVESKK KAVQRLEEQL MKLEVQATDR EENKQIALGT
SKLNYLDPRI TVAWCKKWGV PIEKIYNKTQ REKFAWAIDM TDEDYEF
